BC
MDXG icon

Burleson & Co’s MiMedx Group MDXG Stock Holding History

Burleson & Co’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$5.56K Hold
2,000
– – ﹤0.01% 301
2022
Q3 		$6K Hold
2,000
– – ﹤0.01% 307
2022
Q2 		$7K Hold
2,000
– – ﹤0.01% 283
2022
Q1 		$9K Hold
2,000
– – ﹤0.01% 272
2021
Q4 		$12K Hold
2,000
– – ﹤0.01% 254
2021
Q3 		$12K Buy
+2,000
New +$22.5K ﹤0.01% 254

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Burleson & Co's MDXG Position: Q4 2022 in Review

Burleson & Co held its MiMedx Group (MDXG) position steady in Q4 2022 at 2,000 shares worth $5.56K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

Burleson & Co first reported a position in MDXG in Q3 2021 and has held it in 6 quarters since. The position peaked at $12K in Q4 2021. 152 funds tracked by Wall St. Rank hold MDXG as of Q4 2022.

  • Burleson & Co held 2,000 shares of MiMedx Group worth $5.56K as of Q4 2022.
  • Burleson & Co left its MiMedx Group share count unchanged in Q4 2022.
  • MiMedx Group made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #301 holding.
  • Burleson & Co first reported a position in MiMedx Group in Q3 2021 and has held it in 6 quarters since.
  • Burleson & Co's MiMedx Group position peaked at $12K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.